Freedom-to-Operate Analysis for Engineered Bacterial Enzyme

PROBLEM STATEMENT

The Client’s Challenge

A client was evaluating a bacterial enzyme with potential antimicrobial applications and needed to understand the patent landscape surrounding its proposed use.

The investigation focused on a particularly narrow technical combination: a bacterial lactoperoxidase meeting a defined sequence-identity threshold relative to CyanoPOX, its encapsulation within a biological container known as an encapsulin, and its potential use in applications including personal care.

The relevant patent landscape had to be examined across the intersection of sequence, function, biological source, encapsulation and application.

The target enzyme needed to:

- Demonstrate at least 80% pairwise sequence identity with CyanoPOX.
- Function as a peroxidase with antimicrobial potential.
- Operate in the presence of hydrogen peroxide to support the desired oxidative reaction.
- Be capable of being encapsulated within an encapsulin, a protein-based biological container.
- Support potential downstream applications including personal-care products.

CLIENT’S OBJECTIVE

Assess the patent landscape surrounding a bacterial enzyme technology across the US, WO, EP and CN jurisdictions

Focus on disclosures combining the required sequence similarity, peroxidase functionality, encapsulation and intended applications.

Traditional Investigation Approach

The investigation began with a conventional patent-search framework. The invention was decomposed into its principal technical components, after which keywords, synonyms, classifications and related concepts were developed. The initial search considered:

Conventional Investigation Strategy

Bacterial peroxidases

Lactoperoxidase-related enzymes

CyanoPOX and related sequences

Antimicrobial applications

Detergent applications

The biological nature of the invention created a problem. The same technical concept could be described in a patent through sequence identifiers, functional language, organism names, enzyme classifications or application-specific terminology. A keyword-only strategy therefore risked missing relevant disclosures.

Traditional FTO Investigation Workflow

Technology & Feature Decomposition

Identify core enzyme functionality
Define sequence identity threshold
Map encapsulation and applications

Keyword & Synonym Search

Develop enzyme-related keywords
Identify functional terminology
Search application-specific concepts

Patent Classification Search

Identify relevant CPC/IPC classes
Search biotechnology classifications
Examine encapsulation classifications

Patent Database Screening

Search across target jurisdictions
Review abstracts, claims, descriptions
Prioritize relevant patent families

Sequence-Based Searching

Identify disclosed protein sequences
Compare sequences against CyanoPOX
Screen sequence identity thresholds

Assignee & Inventor Investigation

Identify relevant patent assignees
Trace recurring inventors
Examine related patent families

Citation & Similarity Analysis

Review backward and forward citations
Conduct patent similarity searches
Identify related technical disclosures

Functional & Application Review

Verify peroxidase functionality
Assess antimicrobial applications
Examine encapsulation and formulations

Reference-Level FTO Assessment

Compare sequence similarity thresholds
Assess functional and application overlap
Identify technical disclosure gaps

Outcome: Identify potentially relevant patent disclosures and biological sequences while assessing their sequence, functional, encapsulation and application relevance across jurisdictions.

Limitations of Traditional Approaches

Sequence similarity may not be apparent from patent terminology.
Function and sequence identity are separate technical questions.
Similar sequences may not perform the required enzymatic function.
Relevant application disclosures may appear in unrelated technical contexts such as detergents or hygiene products.
Encapsulation disclosures may be separated from enzyme-specific terminology.
Jurisdiction-specific patent records may describe the same technical concept differently.

The investigation therefore required a method capable of determining not only what a patent said, but also how closely the disclosed biological sequence related to the target enzyme.

Start a Conversation →

Wissen’s Out-of-the-Box Approach:

From Sequence Matching to Multi-Dimensional FTO Analysis

The investigation revealed an important limitation in approaching biotechnology FTO through conventional patent searching alone.
The target technology was not defined by a single characteristic. Its potential relevance depended on the intersection of several technical dimensions:

The bacterial enzyme and its biological source
Sequence identity relative to CyanoPOX
Peroxidase functionality
Encapsulation within a biological container
Antimicrobial activity

Identifying the Relevant Technical Intersection

Rather than treating every sequence hit as an equivalent patent risk, the investigation established a series of technical filters.
This framework allowed technically related references to be distinguished from references that merely appeared similar at a surface level.
For example, a reference discussing a bacterial peroxidase in a detergent formulation could be relevant from an application perspective even if its sequence did not satisfy the client’s 80% threshold.
The investigation therefore evaluated technical relationships rather than relying solely on terminology overlap.

Our Methodology

Conventional Search Limitations

Keyword searches may miss sequence-level disclosures
Enzyme names may vary across technical literature
Sequence similarity does not establish functional equivalence
Application and encapsulation disclosures may appear in separate technical contexts

Technology Decomposition

Establish the 80% sequence-identity threshold relative to CyanoPOX
Define relevant biological and commercial use cases
Develop search concepts for each technical dimension

Broad Patent Landscape Investigation

Search US, WO, EP and CN patent landscapes
Use Orbit and PatSnap for structured patent searching
Supplement with Lens and Google Patents
Investigate classifications, assignees, inventors and patent families

Biosequence Similarity Analysis

Compare disclosed biological sequences against CyanoPOX
Identify high-, moderate- and lower-similarity candidates
Prioritize references meeting or approaching the defined 80% threshold
Separate sequence similarity from functional relevance

Functional Correlation

Examine whether identified sequences correspond to relevant peroxidase activity
Evaluate bacterial source and enzyme characteristics
Identify disclosures involving hydrogen peroxide-dependent activity
Exclude technically unrelated sequence matches

Encapsulation & Application Mapping

Search for biological encapsulation and encapsulin-related disclosures
Identify antimicrobial and hygienic applications
Evaluate detergent and personal-care disclosures
Correlate application-specific disclosures with enzyme and sequence evidence

Cross-Validation & Similarity Searching

Conduct citation and similarity searches around relevant references
Trace related patent families and technical disclosures
Cross-check findings across multiple databases
Compare sequence, function and application evidence

FTO Risk Assessment

Identify references presenting potential technical overlap
Distinguish complete from partial technical matches
Prioritize references for detailed claim-level legal assessment
Provide a structured view of potential FTO considerations

Biosequence Analysis Methodology

The investigation moved beyond conventional patent searching by treating the 80% sequence-identity threshold as a technical gateway for identifying potentially relevant biological disclosures.

A US reference demonstrated approximately 82% sequence similarity with the specified CyanoPOX sequence, exceeding the client’s 80% threshold. However, sequence similarity by itself did not establish that the disclosed enzyme addressed every other technical requirement.

A CN reference showed ~75% sequence similarity and disclosed peroxidase use in detergent and personal-care applications, while a WO reference showed ~61.54% alignment with cyanobacterial heme peroxidases. Another CN reference reported 50–60% similarity and addressed bacterial peroxidase encapsulation for hygienic applications.

Evidence Collection and Validation

The evidence was collected and cross-validated through multiple complementary sources, including:

Patent databases

Biosequence analysis

Patent disclosure analysis

Application-specific evidence

Similarity and citation searches

Assignee and inventor searches

The multi-dimensional analysis established that the patent landscape contained meaningful disclosures around several components of the proposed technology, including closely related enzyme sequences, bacterial peroxidase functionality, encapsulation and personal-care or hygiene applications.

Technical Challenges Addressed Through Biosequence & FTO Analysis

Challenge 1: Could an 80% Sequence Match Identify a Potentially Relevant Enzyme?

The first technical challenge was determining whether previously disclosed bacterial enzyme sequences could meet the client’s defined 80% pairwise sequence-identity threshold relative to CyanoPOX.

Solution

Biosequence analysis was incorporated into the patent investigation to compare candidate enzyme sequences against the specified CyanoPOX sequence.

The analysis revealed:

Approximately 82% sequence similarity in one US reference
Approximately 75% similarity in a CN reference
Approximately 61.54% alignment in a WO reference
Approximately 50–60% similarity in another CN reference

The investigation also demonstrated an important limitation: Sequence similarity alone did not establish that the identified enzyme satisfied the complete technical requirements of the proposed technology. This made sequence analysis a critical FTO screening dimension, rather than a standalone conclusion of patent overlap.

Challenge 2: Could Encapsulation and End-Use Applications Complete the FTO Picture?

A patent discussing bacterial peroxidase might not discuss encapsulation. Another might describe encapsulation without emphasizing the specific enzyme sequence. Yet another might disclose the enzyme in detergent or personal-care applications. The relevant FTO picture could therefore be distributed across different technical disclosures.

Solution

The analysis identified a CN reference reporting approximately 50–60% sequence similarity with the CyanoPOX sequence that also discussed encapsulation of a bacterial peroxidase for use in a hygienic agent.

Separately, the approximately 75% sequence-similarity CN reference discussed bacterial-synthesized peroxidase in detergent and personal-care applications.

Different references provided different pieces of the technical puzzle:

One reference provided the strongest sequence correlation.
Another combined sequence similarity with peroxidase and personal-care/detergent applications.
Another connected bacterial peroxidase with encapsulation.
Another provided a lower sequence-similarity disclosure involving cyanobacterial heme peroxidase.

The resulting evidence showed that the 80% sequence threshold, enzyme function, encapsulation and intended application could not be treated as interchangeable search criteria.

Results & Business Impact

The investigation provided the client with a more structured view of the patent landscape surrounding the proposed bacterial enzyme technology.

Key Outcomes

Identification of a US reference reporting approximately 82% sequence similarity with the specified CyanoPOX sequence.
Identification of a CN reference reporting approximately 75% similarity while also addressing bacterial peroxidase use in detergent and personal-care applications.
Identification of a WO reference reporting approximately 61.54% alignment and discussing bacterial heme peroxidases from cyanobacterial sources.
Identification of a CN reference reporting approximately 50–60% similarity and describing encapsulation of bacterial peroxidase for a hygienic application.
Identification of relevant disclosures across US, WO, EP and CN jurisdictions.
Separation of sequence similarity from functional and application relevance.

Strategic Business Impact

For organizations developing engineered enzymes, this approach can help:

Identify potentially relevant patent families earlier.
Distinguish sequence-related risk from functional overlap.
Identify application-specific disclosures that conventional enzyme searches may miss.
Reveal encapsulation and formulation-related patent considerations.
Prioritize references for detailed claim-level legal review.

Biotechnology patent landscapes often behave differently from conventional technology landscapes. For biological inventions, the identity of the technology may instead be distributed across a sequence, biological function, host organism, formulation, delivery mechanism and commercial application.

Conclusion & Implications

The investigation began with a narrowly defined biological target: a bacterial lactoperoxidase-related enzyme requiring at least 80% sequence identity with CyanoPOX, together with encapsulation and potential personal-care applications.
Traditional patent searching identified several technically relevant references, but the evidence was distributed across different dimensions of the technology.
The investigation therefore expanded into biosequence analysis and multi-dimensional patent searching across the US, WO, EP and CN landscapes.
This approach identified an approximately 82% sequence-similar reference, alongside additional references addressing lower sequence similarity, bacterial peroxidase functionality, encapsulation, hygienic applications, detergents and personal-care products.

Could an 80% Sequence Match Be the Missing Piece in Assessing Biotech FTO Risk?